指南与共识治疗药物监测与药物基因组学特殊人群用药

β-内酰胺类抗生素延长输注国际共识建议

International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Di
指南 / 共识 · Pharmacotherapy · 2023-01-01

该国际共识由临床药学与医学专家小组制定,针对静脉β-内酰胺类抗生素延长输注(包括延长和持续输注)提供治疗推荐,涵盖药代动力学/药效学靶值、治疗药物监测考虑,以及重症与非重症成人、儿童和肥胖患者的应用,并获得多个学会认可。

要点

  • β-内酰胺类呈时间依赖性杀菌,延长输注可增加血药浓度高于最低抑菌浓度的时间。
  • 共识推荐涉及药代动力学/药效学靶值和治疗药物监测 considerations。
  • 推荐适用于重症与非重症成人、儿童及肥胖患者。

核心结论

  • 国际专家小组就β-内酰胺类延长输注达成首个共识治疗推荐,并获得多个学会认可。

研究设计与样本

  • 由临床药学与医学专家组成的国际小组制定共识治疗推荐。

主要发现

  • β-内酰胺类杀菌呈时间依赖性,延长输注可增加游离药物浓度高于最低抑菌浓度的时间。
  • 共识推荐涵盖药代动力学/药效学靶值、治疗药物监测考虑及特定人群应用。

关键数值与推荐

  • 推荐涉及药代动力学/药效学靶值和治疗药物监测考虑。
  • 推荐人群包括重症与非重症成人、儿童和肥胖患者。

临床怎么用

  • 临床可参考该共识在适当患者中实施β-内酰胺类延长输注,并结合治疗药物监测优化给药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intravenous β-lactam antibiotics remain a cornerstone in the management of bacterial infections due to their broad spectrum of activity and excellent tolerability. β-lactams are well established to display time-dependent bactericidal activity, where reductions in bacterial burden are directly associated with the time that free drug concentrations remain above the minimum inhibitory concentration (MIC) of the pathogen during the dosing interval. In an effort to take advantage of these bactericidal characteristics, prolonged (extended and continuous) infusions (PI) can be applied during the administration of intravenous β-lactams to increase time above the MIC. PI dosing regimens have been implemented worldwide, but implementation is inconsistent. We report consensus therapeutic recommendations for the use of β-lactam PI developed by an expert international panel with representation from clinical pharmacy and medicine. This consensus guideline provides recommendations regarding pharmacokinetic and pharmacodynamic targets, therapeutic drug monitoring considerations, and the use of PI β-lactam therapy in the following patient populations: severely ill and nonseverely ill adult patients, pediatric patients, and obese patients. These recommendations provide the first consensus guidance for the use of β-lactam therapy administered as PIs and have been reviewed and endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of America (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists (SIDP).

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Hong LT, Downes KJ, FakhriRavari A, et al. International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary. Pharmacotherapy. 2023. PMID: 37615244. doi:10.1002/phar.2844

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。